Necrotizing Ulcerative Gingivitis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Necrotizing Ulcerative Gingivitis (NUG) Treatment Landscape

Novartis International AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sanofi S.A.
GlaxoSmithKline plc
Merck & Co., Inc.
Otsuka Pharmaceutical Co., Ltd.
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics Limited

Browse Key Market Insights with Data Illustration:

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market | Growth Outlook 2035

In the News

Sanofi S.A. declared an agreement with Septodont to divest a portfolio of the four dental care brands which include Ultracain, Rodogyl, Birodogyl, and Dontisolon, and medical devices. The portfolio contains medicines that are useful for both during and after dental operations.
U.S. Food and Drug Administration recalled a GUM PerioSheild, an oral health rinse of SUNSTAR as it was found contaminated with Burkholderia cepacian microorganisms.

Frequently Asked Questions (FAQ)

Growing incidences of oral diseases, and poor diet and dental hygiene are the major factors driving the market growth.

The market size of necrotizing ulcerative gingivitis (NUG) treatment is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2023-2035.

Lack of health awareness amongst people and discomfort during treatment procedures are estimated to be the growth hindering factors for the market expansion

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment, distribution channel, and by region.

The medication segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Necrotizing Ulcerative Gingivitis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Necrotizing Ulcerative Gingivitis (NUG) Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the necrotizing ulcerative gingivitis (NUG) treatment market?

What would be the CAGR of necrotizing ulcerative gingivitis (NUG) treatment market over the forecast period?

What are the challenges affecting the necrotizing ulcerative gingivitis (NUG) treatment market growth?

Which region will provide more business opportunities for growth of necrotizing ulcerative gingivitis (NUG) treatment market in future?

Who are the major players dominating the necrotizing ulcerative gingivitis (NUG) treatment market?

How are the company profiles selected?

What are the segments in the necrotizing ulcerative gingivitis (NUG) treatment market?

Which segment captures the largest market size in the treatment segment in the necrotizing ulcerative gingivitis (NUG) treatment market?